{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:55:16Z","timestamp":1792090516733,"version":"4.4.0"},"reference-count":34,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K23AI157914"],"award-info":[{"award-number":["K23AI157914"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Int AIDS Soc."],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Tuberculosis (TB) preventive treatment (TPT) is recommended for people living with HIV (PLHIV) in high TB burden settings. While 6 months of daily isoniazid remains widely used, shorter regimens are now available. However, little is known about preferences of PLHIV for key features of TPT regimens.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>From July to November 2022, we conducted a discrete choice experiment among adult PLHIV engaged in care at an urban HIV clinic in Kampala, Uganda. Participants chose between two hypothetical TPT regimens with five different features (pills per dose, frequency, duration, need for adjusted antiretroviral therapy [ART] dosage and side effects), organized across nine random choice tasks. We analysed preferences using hierarchical Bayesian estimation, latent class analysis and willingness\u2010to\u2010trade simulations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 400 PLHIV, 392 (median age 44, 72% female, 91% TPT\u2010experienced) had high\u2010quality choice task responses. Pills per dose was the most important attribute (relative importance 32.4%, 95% confidence interval [CI] 31.6\u201333.2), followed by frequency (20.5% [95% CI 19.7\u201321.3]), duration (19.5% [95% CI 18.6\u201320.5]) and need for ART dosage adjustment (18.2% [95% CI 17.2\u201319.2]). Latent class analysis identified three preference groups: one prioritized less frequent, weekly dosing (<jats:italic>N<\/jats:italic> = 222; 57%); another was averse to ART dosage adjustment (<jats:italic>N<\/jats:italic> = 107; 27%); and the last prioritized short regimens with fewer side effects (<jats:italic>N<\/jats:italic> = 63; 16%). All groups highly valued fewer pills per dose. Overall, participants were willing to accept a regimen of 2.8 months\u2019 additional duration [95% CI: 2.4\u20133.2] to reduce pills per dose from five to one, 3.6 [95% CI 2.4\u20134.8] months for weekly rather than daily dosing and 2.2 [95% CI 1.3\u20133.0] months to avoid ART dosage adjustment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>To align with preferences of PLHIV in Uganda, decision\u2010makers should prioritize the development and implementation of TPT regimens with fewer pills, less frequent dosing and no need for ART dosage adjustment, rather than focus primarily on duration of treatment.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jia2.26390","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T08:24:33Z","timestamp":1732609473000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Preferences of people living with HIV for features of tuberculosis preventive treatment regimens in Uganda: a discrete choice experiment"],"prefix":"10.1002","volume":"27","author":[{"given":"H\u00e9l\u00e8ne E.","family":"Aschmann","sequence":"first","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine University of California San Francisco San Francisco California USA"},{"name":"Department of Epidemiology and Biostatistics University of California San Francisco San Francisco California USA"},{"name":"Center for Tuberculosis University of California San Francisco San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1234-4321","authenticated-orcid":false,"given":"Allan","family":"Musinguzi","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration Kampala Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian L.","family":"Kadota","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine University of California San Francisco San Francisco California USA"},{"name":"Center for Tuberculosis University of California San Francisco San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Namale","sequence":"additional","affiliation":[{"name":"Uganda Tuberculosis Implementation Research Consortium, Walimu Kampala Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet","family":"Kakeeto","sequence":"additional","affiliation":[{"name":"Uganda Tuberculosis Implementation Research Consortium, Walimu Kampala Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Nakimuli","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration Kampala Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Akello","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration Kampala Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Welishe","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration Kampala Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Nakitende","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration Kampala Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Berger","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine University of California San Francisco San Francisco California USA"},{"name":"Center for Tuberculosis University of California San Francisco San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0624-7640","authenticated-orcid":false,"given":"David W.","family":"Dowdy","sequence":"additional","affiliation":[{"name":"Uganda Tuberculosis Implementation Research Consortium, Walimu Kampala Uganda"},{"name":"Department of Epidemiology Johns Hopkins Bloomberg School of Public Health Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adithya","family":"Cattamanchi","sequence":"additional","affiliation":[{"name":"Center for Tuberculosis University of California San Francisco San Francisco California USA"},{"name":"Uganda Tuberculosis Implementation Research Consortium, Walimu Kampala Uganda"},{"name":"Division of Pulmonary Diseases and Critical Care Medicine University of California Irvine Irvine California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0481-7475","authenticated-orcid":false,"given":"Fred C.","family":"Semitala","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration Kampala Uganda"},{"name":"Department of Medicine Makerere University College of Health Sciences Kampala Uganda"},{"name":"Makerere University Joint AIDS Program Kampala Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5023-6658","authenticated-orcid":false,"given":"Andrew D.","family":"Kerkhoff","sequence":"additional","affiliation":[{"name":"Center for Tuberculosis University of California San Francisco San Francisco California USA"},{"name":"Division of HIV, Infectious Diseases, and Global Medicine University of California San Francisco San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,11,26]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"crossref","unstructured":"World Health Organization.WHO consolidated guidelines on tuberculosis. Module 1 Prevention: tuberculosis preventive treatment.2020.","DOI":"10.30978\/TB2021-2-86"},{"key":"e_1_2_11_3_1","volume-title":"Latent tuberculosis infection: updated and consolidated guidelines for programmatic management","author":"World Health Organization","year":"2018"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-022-01167-1"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-016-0429-5"},{"issue":"2","key":"e_1_2_11_6_1","article-title":"Experimental measurement of preferences in health and healthcare using best\u2010worst scaling: an overview","volume":"6","author":"M\u00fchlbacher AC","year":"2016","journal-title":"Health Econ Rev"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.543046"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-018-0954-6"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2017.04.007"},{"key":"e_1_2_11_10_1","first-page":"1","article-title":"The CBC system for choice\u2010based conjoint analysis","volume":"9","author":"Sawtooth Software","year":"2017","journal-title":"Sawtooth Software Technical Paper Series"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.08.2223"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1101\/2023.09.13.23295043"},{"key":"e_1_2_11_13_1","volume-title":"Global multidimensional poverty index 2018: the most detailed picture to date of the world's poorest people","author":"Oxford Poverty and Human Development Initiative","year":"2018"},{"key":"e_1_2_11_14_1","volume-title":"Getting started with conjoint analysis: strategies for product design and pricing research","author":"Orme BK","year":"2006"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.29091"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/0095798420930932"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1037\/tps0000176"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-017-0575-4"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4423"},{"key":"e_1_2_11_20_1","article-title":"Sawtooth Software estimating willingness to pay","author":"Orme BK","year":"2021","journal-title":"Sawtooth Software Research Paper Series"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.20.0956"},{"issue":"2","key":"e_1_2_11_22_1","first-page":"83","article-title":"Preference for daily (1HP) versus weekly (3HP) isoniazid\u2010rifapentine among people living with HIV in Uganda","volume":"1","author":"Musinguzi A","year":"2024","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-048443"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-10098-5"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.17.0809"},{"key":"e_1_2_11_26_1","unstructured":"World Health Organization.Update on the transition to dolutegravir\u2010based antiretroviral therapy: report of a WHO meeting 29\u201330 March 2022. Accessed August 3 2023. Available from:https:\/\/www.who.int\/publications\/i\/item\/9789240053335"},{"key":"e_1_2_11_27_1","volume-title":"WHO operational handbook on tuberculosis. Module 1: Prevention\u2014tuberculosis preventive treatment","author":"World Health Organization","year":"2020"},{"key":"e_1_2_11_28_1","unstructured":"ImperialMZ LuetkemeyerA DawsonR CramerY RosenkranzS SwindellsS et\u00a0al.DTG PK in people with HIV receiving daily 1HP for latent TB treatment (ACTG A5372). CROI.2022. p.78."},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.18.0740"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000391021.18284.12"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-020-01025-8"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.05.003"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.04.004"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czn047"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004356"}],"container-title":["Journal of the International AIDS Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jia2.26390","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T04:16:25Z","timestamp":1735186585000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jia2.26390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1002\/jia2.26390"],"URL":"https:\/\/doi.org\/10.1002\/jia2.26390","archive":["Portico"],"relation":{},"ISSN":["1758-2652","1758-2652"],"issn-type":[{"value":"1758-2652","type":"print"},{"value":"1758-2652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,26]]},"assertion":[{"value":"2024-11-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e26390"}}